Biotech Values

[biomaven0]

>>Finally, just as a related note: being stat sig OS resected vs unresected AND stat sig more resected is no guarantee that the HR is even the right direction overall. All depends on how the survival curves cross.

Agreed. But strong likelihood that prior to resection deaths are roughly equivalent, and pam has a placebo-like AE profile.

In locally advanced pancreatic cancer, there is essentially a 100% death rate within 2 years absent a successful resection. So if the FDA doesn't agree to successful resection as an endpoint, then maybe the best endpoint would be alive at 2 years post diagnosis.